Cart
sales@molnova.com
Tyrphostin AG 112
CAS No. 144978-82-5
Tyrphostin AG 112( —— )
Catalog No. M22092 CAS No. 144978-82-5
Tyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 122 | In Stock |
|
| 50MG | 179 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 647 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTyrphostin AG 112
-
NoteResearch use only, not for human use.
-
Brief DescriptionTyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
DescriptionTyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number144978-82-5
-
Formula Weight236.23
-
Molecular FormulaC13H8N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (529.15 mM)
-
SMILESNC(=C(/C#N)C#N)\C(C#N)=C\c1ccc(O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rodrigo Franco, et al. Epidermal Growth Factor Receptor Is Activated by Hyposmolarity and Is an Early Signal Modulating Osmolyte Efflux Pathways in Swiss 3T3 Fibroblasts. Pflugers Arch. 2004 Mar;447(6):830-9.
molnova catalog
related products
-
Epidermal Growth Fac...
Epidermal Growth Factor?binds to epidermal growth factor receptor (EGFR) and stimulates cell growth and proliferation. It is approved for the treatment of diabetic foot ulcers.
-
Afatinib dimaleate
An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.
-
Tarlox-TKI
Tarlox-TKI (Kinase inhibitor-1) is a pan-ErbB inhibitor, the active ingredient of Tarloxotinib, with antitumor activity.Tarlox-TKI inhibits NRG1 and suppresses HER2 mutants.
